相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Avian influenza vaccines against H5N1 'bird flu'
Chengjun Li et al.
TRENDS IN BIOTECHNOLOGY (2014)
H7N9: a low pathogenic avian influenza A virus infecting humans
Jun Liu et al.
CURRENT OPINION IN VIROLOGY (2014)
Multifunctional Dendritic Sialopolymersomes as Potential Antiviral Agents: Their Lectin Binding and Drug Release Properties
Ali Nazemi et al.
LANGMUIR (2013)
Design and synthesis of a click high-mannose oligosaccharide mimic emulating Man8 binding affinity towards Con A
Virginie Cendret et al.
CHEMICAL COMMUNICATIONS (2012)
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy
L. G. Durrant et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Recent Development in Carbohydrate Based Anticancer Vaccines
Zhaojun Yin et al.
JOURNAL OF CARBOHYDRATE CHEMISTRY (2012)
Chemo-bacterial synthesis and immunoreactivity of a brain HNK-1 analogue
Ludovic Bastide et al.
CARBOHYDRATE RESEARCH (2011)
High-throughput neuraminidase substrate specificity study of human and avian influenza A viruses
Yanhong Li et al.
VIROLOGY (2011)
Synthesis and evaluation of protein conjugates of GM3 derivatives carrying modified sialic acids as highly immunogenic cancer vaccine candidates
Shichong Yu et al.
MEDCHEMCOMM (2011)
Advances in the Biology and Chemistry of Sialic Acids
Xi Chen et al.
ACS CHEMICAL BIOLOGY (2010)
Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
Steven J. Gamblin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Parallel chemoenzymatic synthesis of sialosides containing a C5-diversified sialic acid
Hongzhi Cao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Induction of a Melanoma-Specific Antibody Response by a Monovalent, but not a Divalent, Synthetic GM2 Neoglycopeptide
S. Bay et al.
CHEMMEDCHEM (2009)
Design, Synthesis, and Evaluation of N-Acyl Modified Sialic Acids as Inhibitors of Adenoviruses Causing Epidemic Keratoconjunctivitis
Susanne Johansson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Detection of carbohydrate-binding proteins by oligosaccharide-modified polypyrrole interfaces using electrochemical surface plasmon resonance
Chantal Gondran et al.
ANALYST (2008)
Development of a sialic acid-containing hydrogel of poly[N-(2-hydroxypropyl) methacrylamide]: Characterization and implantation study
Stephane Woerly et al.
BIOMACROMOLECULES (2008)
Fluorination of mammalian cell surfaces via the sialic acid biosynthetic pathway
Laila Dafik et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell
Qianli Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Metabolic oligosaccharide engineering: perspectives, applications, and future directions
Christopher T. Campbell et al.
MOLECULAR BIOSYSTEMS (2007)
Efficient metabolic engineering, of GM3 on tumor cells by N-phenylacetyl-D-mannosamine
P Chefalo et al.
BIOCHEMISTRY (2006)
One-pot three-enzyme chemoenzymatic approach to the synthesis of sialosides containing natural and non-natural functionalities
Hai Yu et al.
NATURE PROTOCOLS (2006)
Large-scale synthesis of H-antigen oligosaccharides by expressing Helicobacter pylori alpha 1,2-fucosyltransferase in metabolically engineered Escherichia coli cells
S Drouillard et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
MD de Jong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Glycans in cancer and inflammation. Potential for therapeutics and diagnostics
DH Dube et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines
YB Pan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Large scale in vivo synthesis of globotriose and globotetraose by high cell density culture of metabolically engineered Escherichia coli
T Antoine et al.
BIOCHIMIE (2005)
Biosynthesis of conjugatable saccharidic moieties of GM(2) and GM(3) gangliosides by engineered E-coli
S Fort et al.
CHEMICAL COMMUNICATIONS (2005)
Highly efficient biosynthesis of the oligosaccharide moiety of the GD3 ganglioside by using metabolically engineered Escherichia coli
T Antoine et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin
LM Krug et al.
CLINICAL CANCER RESEARCH (2004)
Accessibility of N-acyl-D-mannosamines to N-acetyl-D-neuraminic acid aldolase
YB Pan et al.
CARBOHYDRATE RESEARCH (2004)
Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells
W Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Purification of the Porcine rubulavirus attachment protein by liquid isoelectric focusing
G Santos-López et al.
PROTEIN EXPRESSION AND PURIFICATION (2004)
Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli
T Antoine et al.
CHEMBIOCHEM (2003)
Biological properties of N-acyl and N-haloacetyl neuraminic acids:: Processing by enzymes of sialic acid metabolism, and interaction with influenza virus
AJ Humphrey et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria
B Priem et al.
GLYCOBIOLOGY (2002)
Chemical diversity in the sialic acids and related α-keto acids:: An evolutionary perspective
T Angata et al.
CHEMICAL REVIEWS (2002)
An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses
CT Guo et al.
GLYCOBIOLOGY (2002)
Biochemical engineering of the N-acyl side chain of sialic acid:: biological implications
OT Keppler et al.
GLYCOBIOLOGY (2001)
Biochemical engineering of surface α2-8 polysialic acid for immunotargeting tumor cells
TM Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)